Article ID Journal Published Year Pages File Type
2116011 Cancer Letters 2006 9 Pages PDF
Abstract

BARD1 is a crucial partner of the breast and ovarian tumor suppressor BRCA1 required for ubiquitin ligase activity and for reciprocal stabilization in cells. We report here an alternatively spliced human BARD1 mRNA variant (BARD1ΔRIN) isolated from a HeLa cell cDNA library. It is characterized by deletion of exons 2–6 that encode most of the RING finger domain and the entire span of ankyrin repeats. ΔRIN transcript was detected in all breast cancer-cell lines studied although its protein expression level was low. ΔRIN does not interact with BRCA1, whereas it interacts with and colocalizes with CstF-50 to cytoplasmic dots. Hence, a deletion variant of BARD1 occurs in cells and may play a distinct role with CstF-50.

Related Topics
Life Sciences Biochemistry, Genetics and Molecular Biology Cancer Research
Authors
, , , , , , , ,